Theranexus
Developing drug combinations that consist of one compound that targets neurons and another that modulates the activity of astrocytes.
Launch date
Employees
Market cap
$5.1m
Enterprise valuation
$4m (Public information from Sep 2024)
Share price
€0.59 ALTHX.PA
Company register number 791889777
Lyon Auvergne-Rhône-Alpes (HQ)
Authorizing premium user...